We can't find the internet
Attempting to reconnect
Something went wrong
Hang in there while we get back on track
£595.00
It has never been this cheap. We have no record of a lower price.
£595 today · cheaper than every other day in the last 3 months
The 2016-2021 Outlook for Therapeutic Monoclonal Antibody (Mab)-Based Products in Greater China
We'll watch every seller, every day. One email when your price arrives.
Price History & Forecast
Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.
Last 61 days · 61 data points (no recent data)
Historical
Generating forecast…
NEW HERE?
Amazon shows you one price. We show you all of them.
Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.
WHAT'S ON THIS PAGE
↑ Price chart
when this has been cheap or pricey
when this has been cheap or pricey
↑ Forecast
where the price is heading next
where the price is heading next
↓ Statistics
all-time high & low, recent range
all-time high & low, recent range
↑ Price alert
name your number, we'll email you
name your number, we'll email you
Price Distribution
Price distribution over 61 days • 1 price levels
Price Analysis
Most common price: £595 (61 days, 100.0%)
Price range: £595 - £595
Price levels: 1 different prices over 61 days
Description
This econometric study covers the latent demand outlook for therapeutic Monoclonal Antibody (Mab)-based products across the regions of Greater China, including provinces, autonomous regions (Guangxi, Nei Mongol, Ningxia, Xinjiang, Xizang - Tibet), municipalities (Beijing, Chongqing, Shanghai, and Tianjin), special administrative regions (Hong Kong and Macau), and Taiwan (all hereafter referred to as "regions"). Latent demand (in millions of U.S. dollars), or potential industry earnings (P.I.E.) estimates are given across some 1,100 cities in Greater China. For each major city in question, the percent share the city is of the region and of Greater China is reported. Each major city is defined as an area of "economic population", as opposed to the demographic population within a legal geographic boundary. For many cities, the economic population is much larger that the population within the city limits; this is especially true for the cities of the Western regions. For the coastal regions, cities which are close to other major cities or which represent, by themselves, a high percent of the regional population, actual city-level population is closer to the economic population (e.g. in Beijing). Based on this "economic" definition of population, comparative benchmarks allow the reader to quickly gauge a city's marketing and distribution value vis-a-vis others. This report does not discuss the specific players in the market serving the latent demand, nor specific details at the product level. The study also does not consider short-term cyclicalities that might affect realized sales. The study, therefore, is strategic in nature, taking an aggregate and long-run view, irrespective of the players or products involved.
Product Specifications
- Format
- paperback
- ASIN
- B014V6CTGG
- Domain
- Amazon UK
- Release Date
- 28 August 2015
- Listed Since
- 03 September 2015
Similar Products You Might Like
99% match
The 2016-2021 Outlook for Therapeutic Monoclonal Antibody (Mab)-Based Products in India
£595.00
26 Aug 2026
99% match
The 2016-2021 Outlook for Therapeutic Monoclonal Antibody (Mab)-Based Products in the United States
£595.00
22 Aug 2026
99% match
The 2016-2021 Outlook for Therapeutic Monoclonal Antibody (Mab)-Based Products in North America & the Caribbean
£425.00
09 Sep 2026
99% match
The 2016 Report on Therapeutic Monoclonal Antibody (Mab)-Based Products: World Market Segmentation by City
£995.00
08 Sep 2026
98% match
The 2025-2030 World Outlook for Therapeutic Monoclonal Antibody (Mab)-Based Products
Price unavailable
97% match
The 2016-2021 Outlook for Media Buying Agencies in Greater China
£595.00
26 Aug 2026
97% match
The 2026-2031 World Outlook for Antibodies
£885.00
27 Aug 2026
97% match
Therapeutic Monoclonal Antibodies: From Lot Release to Stability Testing
Elsevier
£101.99
24 Sep 2026
97% match
The 2016-2021 Outlook for Hepatitis C Virus (HCV) Therapeutics in Greater China
£595.00
26 Aug 2026
97% match
The 2016-2021 Outlook for Media Sales Representatives in Greater China
£595.00
23 Oct 2026
97% match
The 2023-2028 World Outlook for Custom Antibodies
£795.00
13 Sep 2026
97% match
The 2016-2021 Outlook for Gift, Novelty, and Souvenir Stores in Greater China
£595.00
25 Sep 2026
97% match
The 2016-2021 Outlook for Non-Electric Signs, Displays, and Trade Show Exhibits in Greater China
£595.00
25 Aug 2026
97% match
The 2016-2021 Outlook for Over-The-Counter Health Care Products in Greater China
£595.00
25 Aug 2026
97% match
The 2016-2021 Outlook for Enterprise Asset Management Systems (EAM) in Greater China
£595.00
01 Sep 2026
97% match
The 2023-2028 Outlook for Advanced Therapy Medicinal Products in the United States
£520.00
20 Aug 2026
97% match
The 2016-2021 Outlook for Internet Protocol Television (IPTV) Services in India
£595.00
21 Aug 2026
97% match
The 2016-2021 Outlook for Hematology and Oncology Products in the United States
£595.00
18 Sep 2026
97% match
The 2016-2021 Outlook for Laboratory Chemical Reagents in Greater China
£595.00
22 Aug 2026
97% match
The 2026-2031 World Outlook for Autologous Bone Marrow Transplants
£885.00
21 Aug 2026
97% match
The 2016-2021 Outlook for Women's Apparel and Accessories in Greater China
£595.00
22 Aug 2026
97% match
The 2016-2021 Outlook for Metamaterials in Greater China
£595.00
28 Aug 2026
97% match
The 2016-2021 Outlook for Enterprise Service Bus (ESB) Technologies in the United States
£595.00
08 Sep 2026
97% match
The 2023-2028 Outlook for Advanced Therapy Medicinal Products in India
£515.00
21 Aug 2026